跳至主要内容
临床试验/RBR-22z3jy
RBR-22z3jy已完成2 期

Evaluation of the action of the treatment with platelet rich plasma in patients with Behçet Disease

niversidade Estadual de Campinas0 个研究点开始时间: 2019年1月8日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

入选标准

  • Confirmed diagnosis of Behçet disease according to established criteria according International Study Group for Behçet Disease (ISGBD); Minimum recurrence of three episodes of disease activity in the last year; presence of oral/genital ulcers, without corticosteroid use or at most with 10 mg daily (prednisone).

排除标准

  • The exclusion criteria were: involvement of the central nervous system and/or ocular picture in activity, hematological or renal alterations; antecedent of Neoplasia in the last 5 year; use of corticosteroids in daily doses above 10 mg and use of anticoagulants.

研究者

发起方
niversidade Estadual de Campinas

相似试验